You are here: Home / Journal Articles / Scent dog identification of SARS-CoV-2 infections in different body fluids / About

Scent dog identification of SARS-CoV-2 infections in different body fluids

By Paula Jendrny, Friederike Twele, Sebastian Meller, Claudia Schulz, Maren von Köckritz-Blickwede, Albertus Dominicus Marcellinus Eras Osterhaus, Hans Ebbers, Janek Ebbers, Veronika Pilchová, Isabell Pink, Tobias Welte, Michael Peter Manns, Anahita Fathi, Marylyn Martina Addo, Christiane Ernst, Wencke Schäfer, Michael Engels, Anja Petrov, Katharina Marquart, Ulrich Schotte, Esther Schalke, Holger Andreas Volk

View Link (HTM)

Licensed under

Category Journal Articles
Abstract

Background

The main strategy to contain the current SARS-CoV-2 pandemic remains to implement a comprehensive testing, tracing and quarantining strategy until vaccination of the population is adequate. Scent dogs could support current testing strategies.

Methods

Ten dogs were trained for 8 days to detect SARS-CoV-2 infections in beta-propiolactone inactivated saliva samples. The subsequent cognitive transfer performance for the recognition of non-inactivated samples were tested on three different body fluids (saliva, urine, and sweat) in a randomised, double-blind controlled study.

Results

Dogs were tested on a total of 5242 randomised sample presentations. Dogs detected non-inactivated saliva samples with a diagnostic sensitivity of 84% (95% CI: 62.5–94.44%) and specificity of 95% (95% CI: 93.4–96%). In a subsequent experiment to compare the scent recognition between the three non-inactivated body fluids, diagnostic sensitivity and specificity were 95% (95% CI: 66.67–100%) and 98% (95% CI: 94.87–100%) for urine, 91% (95% CI: 71.43–100%) and 94% (95% CI: 90.91–97.78%) for sweat, 82% (95% CI: 64.29–95.24%), and 96% (95% CI: 94.95–98.9%) for saliva respectively.

Conclusions

The scent cognitive transfer performance between inactivated and non-inactivated samples as well as between different sample materials indicates that global, specific SARS-CoV-2-associated volatile compounds are released across different body secretions, independently from the patient’s symptoms. All tested body fluids appear to be similarly suited for reliable detection of SARS-CoV-2 infected individuals.

Submitter

Marcy Wilhelm-South

Purdue University

Date 2021
Publication Title BMC Infectious Diseases
Volume 21
Pages 14
DOI 10.1186/s12879-021-06411-1
Language English
Additional Language English
Cite this work

Researchers should cite this work as follows:

Tags
  1. Animal roles
  2. Canine scent detection
  3. Covid-19
  4. Dogs
  5. Mammals
  6. open access
  7. Pets and companion animals
  8. saliva
  9. sweat
  10. urine
  11. Working animals
Badges
  1. open access